Nice thanks bfost - by the way one theory is that the slightly higher level (1/100 1%) of afib on treatment arm was the EPA doing its job with some desired flutter prior to stroke.
Frost- A.fib is a huge label concern... as you know a.fib increases the risks of thrombotic strokes from atrium clots.... But!!!!! R-I show a 28% RRR reduction in stroke! The FDA needs to get their head out of their asses!!! I need cardiologists to join my complaint. My complaint will be organized, professional and supported by Senate HELP members./—-BB